Relationship Among Amblyopia, Nystagmus, and Fixation Instability And The AI-Guided Robotic Guide Dog, Milo

Dr. Fatema Ghasia (Cleveland Clinic - Cleveland, OH)

Dr. Florian Golemo (Mila Quebec Artificial Intelligence Institute - Montreal, QC)

Joanna Wolski (Mila Quebec Artificial Intelligence Institute - Montreal, QC)

Dr. Fatema Ghasia, Professor, Ophthalmology, Cleveland Clinic, Director, Visual Neurosciences and Ocular Motility Lab, Staff Physician, Cole Eye Institute, explains the relationship among amblyopia, nystagmus, and fixation instability.

Dr. Florian Golemo, Research Scientist, Mila Quebec Artificial Intelligence Institute, and Joanna Wolski, Collaborating Researcher, Mila Quebec Artificial Intelligence Institute, discuss the newly developed AI-guided robotic guide dog, Milo.

10/18/2026 Podcast (Click Image Below) 

Molecular Makeup of Sclera Affecting Glaucoma and Myopia And Erucamide Repairing Retinal Damage

Dr. Yi Hua (University of Mississippi - Oxford, MS)

Dr. Martin Friedlander (Scripps Research - San Diego, CA)

Dr. Yi Hua, Assistant Professor of Biomedical Engineering, Director of the Vision Laboratory, University of Mississippi, discusses how the molecular makeup of the outer wall of the eye, sclera, can have an effect on the development of glaucoma and myopia. 

Dr. Martin Friedlander, Professor, Department of Molecular and Cellular Biology, Scripps Research Institute, Attending Physician, Scripps Clinic Department of Ophthalmology, President, Lowy Medical Research Institute, explains how a molecule, erucamide, helps the eye respond to retinal damage.

10/11/2026 Podcast (Click Image Below)

Stem Cell Therapy Without Suppressing Immune System To Treat Macular Degeneration

Dr. Trevor McGill (Oregon National Primate Research Center - Portland, OR)

Dr. Trevor McGill, Associate Professor, Division of Neuroscience, Oregon National Primate Research Center, Joint Appointment, Casey Eye Institute, Oregon Health and Science University, discusses upcoming research into developing stem cell therapy that would avoid suppressing the immune system to help treat the dry form of age-related macular degeneration.

10/4/2026 Podcast (Click Image Below) 

Blind Americans Return To Work Act and Using AI To Predict Progression Of Glaucoma

Justin Young (National Federation of the Blind - Baltimore, MD)

Dr. Ming Dong and Dr. Karim Dirani (Wayne State University - Detroit, MI)

Dr. Justin Young, government affairs specialist, National Federation of the Blind (NFB), discusses the proposed legislation, Blind Americans Return To Work Act and the Medical Device Nonvisual Accessibility Act and their progress in being passed by Congress.

Dr. Karim Dirani, Resident Physician and Clinical Researcher, Kresge Eye Institute, Wayne State University, and Dr. Ming Dong, Professor of Computer Science, Institute of Artificial Intelligence and Data Science, Wayne State University, discuss how artificial intelligence can be used to predict the progression of glaucoma and visual field loss.

9/27/2026 Podcast (Click Image Below) 

The Blind Kitchen and Research Into Development Of Sharper Central Vision

Debra Erickson (The Blind Kitchen - Portland, OR)

Bob Johnston (Johns Hopkins University - Baltimore, MD)

Debra Erickson, Executive Chef and Founder, The Blind Kitchen, discusses overcoming visual challenges to learn how to cook, teaching others with visual challenges how to cook, and information available from its website.

Dr. Bob Johnston, Professor of Biology, Johns Hopkins University, explains how using lab-grown retinal tissue has shown how a Vitamin A-derivative and thyroid hormones lead to sharp central vision being developed by humans.

9/6/2026 Podcast (Click Image Below) 

Neuroprotective Genes For Retinitis Pigmentosa Treatment and The Foreseeable Future Foundation

Dr. Daniel Kerschensteiner (Washington University - St. Louis, MO)

Dr. Philip Ruzycki (Washington University - St. Louis, MO)

Foreseeable Future Foundation (Franklin, TN)

Dr. Daniel Kerschensteiner, Bernard Becker Professor of Ophthalmology and Visual Sciences, and Dr. Philip Ruzycki, Assistant Professor of Ophthalmology and Visual Sciences, Washington University in St. Louis, discuss how the neuroprotective genes, UFD1 and UXT, were discovered to be tested in gene therapies to treat retinitis pigmentosa.

Then, Griffin Pinkow, CEO and Founder, Foreseeable Future Foundation, explains how the foundation provides programs to empower those who are blind or have low vision through sports and recreation.

 8/30/2026 Podcast (Click Image Below)

GLP-1 Drugs Effect On Ischemic Optic Neuropathy and AI-Assisted Tool To Mitigate African-American Disparities In Eye Care

Dr. Chintan Dave (Rutgers University - New Brunswick, NJ)

Dr. Alvin Liu (Johns Hopkins University - Baltimore, MD)

Dr. Chintan Dave, Associate Professor and Director of Health Outcomes, Policy, and Economics (HOPE), Rutgers University, explains how much the use of GLP-1 drugs affects the risk of developing ischemic optic neuropathy, which involves decreased or blocked blood flow to the optic nerve. 

Dr. Alvin Liu, Professor of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, discusses how an AI-assisted tool can be used to cut down on the disparities in eye care for diabetic African-Americans.

8/16/2026 Podcast (Click Image Below)